Iterative Scopes
Developer of artificial intelligence-based medicine for gastroenterology designed for optimizing clinical trials investi
Outcome Management (Healthcare)
📍 Cambridge, MA
Founded 2017
Current Valuation
$700M
as of 2022-Q1
PRIVATE
Developer of artificial intelligence-based medicine for gastroenterology designed for optimizing clinical trials investigating the treatment of inflammatory bowel disease (IBD).
Company Profile
Last Round
Series B — $150M (Jan 2022)
Fundraising Status
Series B · $150M · 4y 5mo ago
privateTotal raised $194M
Latest Funding Round
| Round | Amount | Date | Lead Investor | Post-Money |
|---|
| Series B | $150M | Jan 2022 | — | $700M |
MedicalHealth CareComputer VisionHealth Diagnostics
Private-company numbers are not real-time. Reflects publicly disclosed valuations from press releases, news reports, and tender offers as of 2022-Q1. Refreshed quarterly.